Skip to main content
Toggle navigation
Search
Home
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
G
Gandolfi, Sara
University of Helsinki
Trainee Forum and Networking Reception
Location: Room 501
Sara Gandolfi
Garcia Sanz, Ramon
Dept. of Hematology, Gregorio Marañón General University Hospital
Meet the Experts: MGRS - diagnosis and management
Location: Room 716A
Ramon Garcia Sanz
Gay, Francesca
Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino
Core Session 2: Risk Adaptation Management
Location: Hall FG
Francesca Gay
Gayle, Arlene
AdventHealth Medical Group
Perspectives on Community Use of BCMA BsAbs: Expanding Access to Novel Therapies
Location: Hall FG
Arlene Gayle
Gertz, Morie
Mayo Clinic Rochester
Round Table discussion
Location: Hall FG
Morie Gertz
Ghobrial, Irene
Dana-Farber Cancer Institute, Boston, MA, USA
Round Table discussion
Location: Hall FG
Irene Ghobrial
Gleason, Charise
Winship Cancer Institute of Emory University
9th Nursing & Allied Health Symposium: Session 1: Cellular Therapies: Building Equity of Access
Location: Room 501
Charise Gleason
9th Nursing & Allied Health Symposium: Welcome
Location: Room 501
Charise Gleason
Optimising patient outcomes through best supportive care: Case-based moderated panel discussion
Location: Room 501
Charise Gleason
Godara, Amandeep
University of Utah
(PA-529) Risk of Infections after Bispecific Antibodies Targeting Anti-B-cell Maturation Antigen (BCMA) in Multiple Myeloma-intravenous Immunoglobulin (IVIG) Significantly Lowers the Risk of Infection
Location: Room 714A
Amandeep Godara
Goldschmidt, Hartmut
Internal Medicine V, GMMG Study Group at University Hospital Heidelberg, Heidelberg, Germany
Poster Discussion
Location: Room 714A
Hartmut Goldschmidt
Gonsalves, Wilson
Mayo Clinic, Rochester
Meet the Experts: Extramedullary disease/PCl
Location: Room 716B
Wilson Gonsalves
(OA-24) Assessment For Circulating Plasma Cell Enhances R2-ISS in Newly Diagnosed Multiple Myeloma
Location: Room 718
Wilson Gonsalves
González-Calle, Verónica
Hematology Department, University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC)
(OA-48) Final Analysis of the GEM-BELA-VRd Phase II Trial: Belantamab Mafodotin Plus VRd in Newly Diagnosed Transplant-Eligible Myeloma After 2 Years of Maintenance with Belantamab and Lenalidomide
Location: Room 701
Verónica González-Calle
(OA-63) Efficacy and Safety of Iberdomide, Daratumumab, and Dexamethasone, in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients: Initial Analysis of the GEM-IBERDARAX trial
Location: Hall FG
Verónica González-Calle
Goqwana, Lindokuhle
University of the Witwaterand
Managing myeloma with limited resources - challenges and opportunities
Location: Delta Hotel
Lindokuhle Goqwana
Green, Damian
Sylvester Comprehensive Cancer Center/University of Miami
Abstract Session 7
Location: Room 701
Damian Green
